Lemaitre Vascular (LMAT) Non-Current Deferred Tax Liability (2010 - 2026)
Lemaitre Vascular's (LMAT) quarterly Non-Current Deferred Tax Liability came in at $2.0 million in Q2 2026, up 2003.16% year-over-year from $95000.0 in Q2 2025, and up 7.71% quarter-over-quarter from $1.9 million in Q1 2026.
Analysis
Lemaitre Vascular (LMAT) Non-Current Deferred Tax Liability (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Non-Current Deferred Tax Liability for 17 consecutive years, with $2.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability rose 2003.16% year-over-year to $2.0 million in Q2 2026; TTM through Jun 2026 was $2.0 million, a 2003.16% increase from a year earlier, with the FY2025 full-year figure at $1.7 million, up 1941.18% from the prior year.
- Non-Current Deferred Tax Liability was $2.0 million for Q2 2026 at Lemaitre Vascular, up from $1.9 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $2.1 million in Q3 2025 and troughed at $60000.0 in Q3 2022.
- A 5-year average of $491722.2 and a median of $91500.0 in 2025 frame the typical range for Non-Current Deferred Tax Liability.
- Across the five-year window, Non-Current Deferred Tax Liability slumped 50.82% in 2022 and surged 2007.95% in 2026, its largest moves.
- Over 5 years, Non-Current Deferred Tax Liability stood at $69000.0 in 2022, then jumped by 55.07% to $107000.0 in 2023, then dropped by 20.56% to $85000.0 in 2024, then jumped by 1941.18% to $1.7 million in 2025, then gained by 15.16% to $2.0 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $2.0 million (Q2 2026), $1.9 million (Q1 2026), and $1.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.00 Mn |
| Mar 31, 2026 | 1.86 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | 2.09 Mn |
| Jun 30, 2025 | 95,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Dec 31, 2024 | 85,000.00 |
| Sep 30, 2024 | 109,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Mar 31, 2024 | 114,000.00 |
| Dec 31, 2023 | 107,000.00 |
| Sep 30, 2023 | 69,000.00 |
| Jun 30, 2023 | 72,000.00 |
| Mar 31, 2023 | 71,000.00 |
| Dec 31, 2022 | 69,000.00 |
| Sep 30, 2022 | 60,000.00 |
| Jun 30, 2022 | 64,000.00 |
| Mar 31, 2022 | 68,000.00 |
| Dec 31, 2021 | 70,000.00 |
| Sep 30, 2021 | 122,000.00 |